5 Tips for Traveling Safely Over Spring Break

Read Featured Post

2021 Minnesota Water Safety

Read Featured Post

2019 Attorneys of the Year: Leonard Pozner/Sandy Hook defamation case

Read Featured Post

Meshbesher & Spence Mourns Loss of Founder

Read Featured Post
Posts Archive
02/23/2023

Smith & Nephew Birmingham Hip Resurfacing and Total Hip Replacements In May of 2006, Smith & Nephew introduced the Birmingham Hip Resurfacing (BHR) through the Premarket Approval (“PMA”) process. A typical total hip replacement system consists of four separate components: 1) a femoral stem; 2) a femoral head; 3) a liner; and 4) an acetabular […]

02/23/2023

Xeljanz, Xeljanz XR, Xeljanz ER (tofacitinib) In 2012, the U.S. Food and Drug Administration (“FDA”) approved the above-named Xeljanz medicine in 2012 to treat moderately to severely active rheumatoid arthritis. It later approved the drug for ulcerative colitis, juvenile arthritis, and psoriatic arthritis. In February 2019, the FDA released a safety alert about an increased […]

02/23/2023

Necrotizing Enterocolitis (NEC) A new study has linked certain baby formulas with an increased risk in necrotizing enterocolitis (NEC). What is NEC? Necrotizing enterocolitis is a digestive disease that impacts newborn children, often times premature babies. The bacteria enters the body and erodes the intestinal lining and causes infection. Some symptoms of NEC are: Metabloic […]

02/23/2023

About the Valsartan Recall Multiple manufacturers have voluntarily recalled their Valsartan medication after the FDA issued its largest-ever Class 1 recall due to N-Nitrosodimethylamine (NDMA) found in supplies that were produced by Zhejiang Huahai Pharmaceutical Co. Ltd. (ZHP). NDMA is a known human carcinogen that can lead to serious health risks in high doses and […]

02/23/2023

Philips Respironics – CPAP Recall On June 14, 2021, Philips Respironics issued a recall notification because of potential health risks associated with the polyester-based polyurethane (PE-PUR) sound reduction foam used in specific Philips Continuous Positive Airway Pressure (CPAP), Bi-Level Positive Airway Pressure (BiLevel PAP) devices, as well as certain mechanical ventilators. Philips acknowledged that the […]

02/23/2023

Losartan Potassium Tablets Date of Recall: December 20, 2018 Recalling Firm(s): Torrent Pharmaceuticals Limited Product: Losartan potassium tablets Scope of recall: BO31C016 ( both 30 & 90 count bottles), 4DK3C005, 4DK3C004, 4DU3C040, 4DU3E049, 4DU3E050, 4L67C035, 4L67C035, 4L67C036, 4O50C005 and 4O49C013. See below. Description: Torrent has voluntarily recalled ten lots of Losartan potassium tablets due to the detection of trace […]

02/23/2023

About the Exactech Recall Medical device company Exactech, Inc., has issued recalls involving specific components used in its knee, hip, and ankle replacement systems due to an increased risk of premature failure. As a result, some patients may require early revision surgery. The polyethylene liners used in many of Exactech’s hip, knee, and ankle devices […]

02/23/2023

Irbesartan and Irbesartan HCTZ Tablets Date of Recall: January 18, 2019 Recalling Firm(s): Prinston Pharmaceutical Inc. Product: Irbesartan and Irbesartan HCTZ Tablets. Scope of recall: Please look below to see specific recalled catalog numbers and associated lot numbers. Description: Prinston Pharmaceutical Inc., dba Solco Healthcare LLC., has voluntarily recalled one lot of Irbesartan and seven lots of Irbesartan HCTZ […]

02/23/2023

About the Zantac Recall Zantac is an over-the-counter (OTC) drug for heartburn, acid indigestion, gastroesophageal reflux disease (GERD), ulcers, and other stomach conditions. The FDA recalled Zantac and its generic formulation, ranitidine, due to increased cancer risk. When exposed to chemicals in the body, Zantac’s active ingredient, ranitidine, may produce dangerous levels of nitrosodimethylamine (NDMA), […]

02/23/2023

What is The Medtronic HeartWare HVAD System? The Medtronic HeartWare HVAD System is a left ventricular assist device or “LVAD” used to treat patients who are awaiting a heart transplant (bridge-to-transplant) and patients who are in end-stage heart failure and not eligible for or are too sick to receive a heart transplant (destination therapy). The […]